Pancreatitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Pancreatitis Clinical Trials Market Report Overview
The Pancreatitis clinical trial market research report provides an overview of the Pancreatitis clinical trials scenario. The report provides top-line data relating to the clinical trials on Pancreatitis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Pancreatitis Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Pancreatitis clinical trials market are Asia Pacific, Europe, North America, Middle East and Africa, and South and Central America. Asia Pacific dominates the market with more than 40% of clinical trials conducted in the region.
In a country-wise analysis, as of April 2022, China has the highest number of Pancreatitis clinical trials, followed by the US, India, Japan, Iran, South Korea, Canada, Spain, Netherlands, and the United Kingdom.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan has the highest proportion of Pancreatitis to Gastrointestinal clinical trials as of April 2022. Moreover, most of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, China has the highest proportion of Pancreatitis to Gastrointestinal clinical trials as of April 2022.
Pancreatitis Clinical Trials Analysis by Regions
For more regional insights into the Pancreatitis clinical trials market, download a free report sample
Pancreatitis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Pancreatitis clinical trials market are institution, company, and the government. Out of them, institution dominates the market with more than 70% of trials.
Pancreatitis Clinical Trials Market Analysis by Sponsor Types
For more sponsor-type insights into the Pancreatitis clinical trials market, download a free report sample
Pancreatitis Clinical Trials Market Segmentation by Prominent Drugs
The key prominent drug types in the Pancreatitis clinical trials market are somatostatin, simvastatin, pancrelipase DR, meperidine, diclofenac, and indomethacin.
Pancreatitis Clinical Trials Market Analysis by Prominent Drugs
For more prominent drug insights into the Pancreatitis clinical trials market, download a free report sample
Pancreatitis Clinical Trials Market - Competitive Landscape
The leading sponsors in the Pancreatitis clinical trials market are AbbVie Inc, Abbott Laboratories, CalciMedica Inc, Asian Institute of Gastroenterology, Shanghai Pharmaceuticals Holding Co Ltd, Shanghai Pharmaceutical Group Co Ltd, Merck & Co Inc, Johnson & Johnson, ChiRhoClin Inc, AstraZeneca Plc, and others. As of April 2022, AbbVie Inc, Abbott Laboratories, and CalciMedica Inc sponsored the highest number of pancreatitis clinical trials.
Pancreatitis Clinical Trials Market Analysis by Sponsors
To know more about the leading players in the Pancreatitis clinical trials market, download a free report sample
Pancreatitis Clinical Trials Market Report Overview
Key Regions | Asia Pacific, Europe, North America, Middle East and Africa, and Central and South America |
Key Countries | China, the US, India, Japan, Iran, South Korea, Canada, Spain, Netherlands, and the United Kingdom |
Key Sponsor Types | Institution, Company, and Government |
Key Pipeline Drugs | Somatostatin, Simvastatin, Pancrelipase DR, Meperidine, Diclofenac, And Indomethacin |
Leading Sponsors | AbbVie Inc, Abbott Laboratories, CalciMedica Inc, Asian Institute of Gastroenterology, Shanghai Pharmaceuticals Holding Co Ltd, Shanghai Pharmaceutical Group Co Ltd, Merck & Co Inc, Johnson & Johnson, ChiRhoClin Inc, AstraZeneca Plc, and others |
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type and end point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reason for unaccomplishment
- The report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies about investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
AbbVie Inc
CalciMedica Inc
Asian Institute of Gastroenterology
Shanghai Pharmaceutical Group Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
AstraZeneca Plc
ChiRhoClin Inc
Johnson & Johnson
Merck & Co Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key regions in the Pancreatitis clinical trials market?
The key regions in the Pancreatitis clinical trials market are Asia Pacific, Europe, North America, Middle East and Africa, and Central and South America.
-
What are the key countries in the Pancreatitis clinical trials market?
The key countries in the Pancreatitis clinical trials market are China, the US, India, Japan, Iran, South Korea, Canada, Spain, Netherlands, and the United Kingdom.
-
What are the key sponsor types in the Pancreatitis clinical trials market?
The key sponsor types in the Pancreatitis clinical trials market are institution, company, and the government.
-
What are the prominent drug types in the Pancreatitis clinical trials market?
The key prominent drug types in the Pancreatitis clinical trials market are somatostatin, simvastatin, pancrelipase DR, meperidine, diclofenac, and indomethacin.
-
Who are the leading sponsors in the Pancreatitis clinical trials market?
The leading sponsors in the Pancreatitis clinical trials market are AbbVie Inc, Abbott Laboratories, CalciMedica Inc, Asian Institute of Gastroenterology, Shanghai Pharmaceuticals Holding Co Ltd, Shanghai Pharmaceutical Group Co Ltd, Merck & Co Inc, Johnson & Johnson, ChiRhoClin Inc, AstraZeneca Plc, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.